A recent Journal of Clinical Medicine study investigates the efficacy of oral semaglutide in patients with type 2 diabetes (T2D). Study: Oral Semaglutide in Routine Clinical Practice: Characteristics ...

Sitagliptin has been approved as a monotherapy and as an add-on therapy to two other types of oral diabetes medications, metformin and thiazolidinediones, to improve glucose control in patients with ...

In a recent study published in the Journal of Clinical Medicine, a group of researchers described the clinical characteristics of patients with type 2 diabetes (T2D) initiating oral semaglutide and ...

Emerging evidence suggests that oral health, often overlooked by clinicians, is closely connected with overall health — and this connection has important consequences for individuals with type 2 ...

Findings from the American College of Cardiology 2025 Annual Scientific Session show oral semaglutide reduces the risk of heart attack, stroke, and cardiovascular death by 14% in patients with type 2 ...

American pharmaceutical company Eli Lilly and Company this week announced results from a late-stage clinical trial for its oral diabetes medicine, orforglipron. The once-daily pill, currently under ...